Sign in Request access
Sign inRequest access
Closed

This opportunity is closed. Its page stays for reference.

Similar open opportunities

ClosedTender

Ex-Ante-Transparenzbekanntmachung § 130c Abs. 1 SGB V Arzneimittelbezeichnung: Bimzelx(R) Wirkstoff: Bimekizumab ATC-Code: L04AC21*

At a glance

AOK Bayern - Die Gesundheitskasse is procuring Pharmaceutical products (CPV 33600000). It is closed. Procedure type: Negotiated without prior call for competition.

From the notice

Arzneimittelrabattvertrag § 130c Abs. 1 SGB V Arzneimittelbezeichnung: Bimzelx(R) Wirkstoff: Bimekizumab ATC-Code: L04AC21

Key facts

Each fact is from the official notice, last checked 26 October 2026, 15:35 (UTC+01:00).

Status
ClosedOfficial notice · checked 26 Oct 2026, 15:35 (UTC+01:00)
Deadline
No deadline in the noticeOfficial notice · checked 26 Oct 2026, 15:35 (UTC+01:00)
Buyer
AOK Bayern - Die Gesundheitskasse, München, DEOfficial notice · checked 26 Oct 2026, 15:35 (UTC+01:00)
Main CPV
Pharmaceutical products (CPV 33600000)Official notice · checked 26 Oct 2026, 15:35 (UTC+01:00)
Procedure
Negotiated without prior call for competitionOfficial notice · checked 26 Oct 2026, 15:35 (UTC+01:00)
Lots
1Official notice · checked 26 Oct 2026, 15:35 (UTC+01:00)
First published
21 October 2026, 17:55 (UTC+02:00)Official notice · checked 26 Oct 2026, 15:35 (UTC+01:00)

Fact sheet

Inteliwert fact sheet: Ex-Ante-Transparenzbekanntmachung § 130c Abs. 1 SGB V Arzneimittelbezeichnung: Bimzelx(R) Wirkstoff: Bimekizumab ATC-Code: L04AC21* — AOK Bayern - Die Gesundheitskasse. A product of Bandpey GmbH.
The key facts of this page as an image (PNG, 1600 × 900), made from the official notice. © Bandpey GmbH; terms of use. Download the fact sheet

Lots (1)

  1. Lot LOT-0001: Ex-Ante-Transparenzbekanntmachung § 130c Abs. 1 SGB V Arzneimittelbezeichnung: Bimzelx(R) Wirkstoff: Bimekizumab ATC-Code: L04AC21*

    Arzneimittelrabattvertrag § 130c Abs. 1 SGB V Arzneimittelbezeichnung: Bimzelx(R) Wirkstoff: Bimekizumab ATC-Code: L04AC21

    CPV
    Pharmaceutical products (CPV 33600000)

Timeline

  1. 21 October 2026, 17:55 (UTC+02:00): Original notice Notice, version 01 (Voluntary ex-ante transparency notice). Official notice

Buyer and place

Buyer

AOK Bayern - Die Gesundheitskasse
München, DE

Other parties in the notice

  • UCB Pharma GmbH (Tenderer), Monheim am Rhein

Classification

CPV codes

  • 33600000: Pharmaceutical products

Official documents

No documents found in the indexed notice.

Questions and answers

Who is the buyer?

AOK Bayern - Die Gesundheitskasse, München, DE.

What is being procured (CPV)?

Pharmaceutical products (CPV 33600000).

Is it divided into lots?

No, the notice names a single lot.

Which procedure is used?

Negotiated without prior call for competition.

How do I submit a bid?

On the official notice or the portal it names. Inteliwert does not submit bids. Official notice

Am I eligible?

Inteliwert does not judge eligibility. The selection criteria are in the official notice. Official notice

More from this buyer

Other published opportunities of this buyer in the indexed notices, open ones first.

Source

Publisher
Bekanntmachungsservice
Licence
CC0 1.0
Last checked
26 October 2026, 15:35 (UTC+01:00)

The official notice is authoritative. Inteliwert shows what the notice states and links to it.

Markdown version